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Abstract
In recent years considerable attention has been given to the use of natural substances as anticancer drugs. The natural
antioxidant dipeptide L-carnosine belongs to this class of molecules because it has been proved to have a significant
anticancer activity both in vitro and in vivo. Previous studies have shown that L-carnosine inhibits the proliferation of
human colorectal carcinoma cells by affecting the ATP and Reactive Oxygen Species (ROS) production. In the present study
we identified the Hypoxia-Inducible Factor 1a (HIF-1a) as a possible target of L-carnosine in HCT-116 cell line. HIF-1a protein
is over-expressed in multiple types of human cancer and is the major cause of resistance to drugs and radiation in solid
tumours. Of particular interest are experimental data supporting the concept that generation of ROS provides a redox signal
for HIF-1a induction, and it is known that some antioxidants are able to suppress tumorigenesis by inhibiting HIF-1a. In the
current study we found that L-carnosine reduces the HIF-1a protein level affecting its stability and decreases the HIF-1
transcriptional activity. In addition, we demonstrated that L-carnosine is involved in ubiquitin-proteasome system
promoting HIF-1a degradation. Finally, we compared the antioxidant activity of L-carnosine with that of two synthetic anti-
oxidant bis-diaminotriazoles (namely 1 and 2, respectively). Despite these three compounds have the same ability in
reducing intracellular ROS, 1 and 2 are more potent scavengers and have no effect on HIF-1a expression and cancer cell
proliferation. These findings suggest that an analysis of L-carnosine antioxidant pathway will clarify the mechanism
underlying the anti-proliferative effects of this dipeptide on colon cancer cells. However, although the molecular
mechanism by which L-carnosine down regulates or inhibits the HIF-1a activity has not been yet elucidated, this ability may
be promising in treating hypoxia-related diseases.
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Introduction
L-Carnosine (b-Ala-His) is a naturally occurring histidine
dipeptide, endogenously synthesized and widely found in the
brain, muscle, kidney, stomach, and, in large amounts, in the
skeletal muscle. This dipeptide has been proved to perform a
number of biological functions, including anti-oxidant activity,
ability to chelate metal ions, inhibition of protein glycosylation,
anti-inflammatory and anti-senescence properties [1]. Another
aspect of the effect of L-carnosine concerns its anti-proliferative
effect in human cell lines. Recently, we have demonstrated that L-
carnosine inhibits the proliferation of human colorectal carcinoma
HCT-116 cells by affecting the ATP and ROS production and by
inducing the cell cycle arrest in G1 phase [2]. In addition, some
authors, with a proteomic approach, support the possibility that
this dipeptide affects tumour cell growth in the human glioma cells
and retards tumour growth in vivo in a NIH3T3-HER2/neu
mouse model through an interference with protein folding/
processing and HIF-1a signalling [3–4]. Actually, considerable
efforts have been directed to the discovery of the chemical or
natural molecules that target HIF-1a protein and regulate HIF-1a
signalling pathway through a variety of molecular mechanisms,
including transcriptional regulation, stabilization, degradation and
transactivation. Of particular interest is the role of ROS and
antioxidant molecules in HIF-1a regulation. Indeed, a series of
compounds, such as rapamicin and resveratrol, have been shown
to be inhibitors of HIF-1a [5–6]. HIF-1a is a component of HIF-1
complex that plays a central role in O2 homeostasis and, in fact, is
considered a central regulator of the adaptation responses of
cancer cells to hypoxia [7]. HIF-1 complex is a heterodimeric
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transcription factor consisting of O2-regulated HIF-1a and
constitutively expressed HIF-1b subunits. Under normoxic condi-
tions the isoform prolyl hydroxylase PHD2 hydroxylates HIF-1a
on two functionally independent proline residues, Pro402 and
Pro564, within the ODD (oxygen-dependent degradation) domain
[8–9]. Hydroxylated Pro residues promote the recruitment of HIF-
1a by Von Hippel-Lindau tumour suppressor protein (VHL), a
recognition module of the E3-ubiquitin ligase, responsible for its
ubiquitination and subsequent proteasome-mediated degradation
[10]. Under hypoxic conditions the HIF-1a protein escapes to
proteolysis, is upregulated, and forms a heterodimer with HIF-1b
in the HIF-1 complex. The HIF-1 complex recognizes and binds
to the hypoxia responsive element (HRE) of the hypoxia-inducible
genes, including genes that influence angiogenesis, iron metabo-
lism, modulation of glucose metabolism, cell proliferation, survival,
and invasion, thereby activating their transcription [11]. In recent
years, HIF-1 has emerged as a promising target for cancer
therapeutics. In fact, HIF-1a over-expression is a common feature
of human cancers, where it mediates the adaptation to the hypoxic
tumour microenvironment. In accordance with these observations,
the purpose of this study was to investigate in HCT-116 cell line
the effects of L-carnosine on the expression of HIF-1a and HIF-
1a-dependent genes. In addition, in recent years of particular
interest it has been the role of ROS and antioxidant molecules in
HIF-1a regulation [12]. Thus, to understand the mechanisms
responsible for the L-carnosine effect we have also examined how
this dipeptide affects ROS intracellular levels in comparison with
two new anti-oxidant bis-diaminotriazole compounds (namely 1
and 2 respectively) available from our laboratories and whose
antioxidant activity is unpublished. Despite these three compounds
have the same ability in reducing intracellular ROS, we found that
1 and 2 have no effect on HIF-1a expression and cancer cell
proliferation. We suppose that the antioxidant activity of L-
carnosine operates with a different mechanism than compounds 1
and 2. Thus, we conclude that an analysis of the L-carnosine
antioxidant pathway will clarify the mechanism underlying the
effects of this dipeptide on colon cancer cells.
Materials and Methods
Cell Culture
HCT-116 human colorectal carcinoma cell line was purchased
from the American Type Culture Collection (ATCC) USA. The
cell line was cultured at 37uC and 5% CO2 in DMEM (Dulbecco’s
Modified Eagle Medium) purchased from BioWhittaker Classic
Cell Culture Media, Lonza - VWR International s.r.l., supple-
mented with 10% fetal bovine serum (FBS) (Gibco Laboratories,
North Andover, Massachusetts) and 1% penicillin/streptomycin
(Gibco Laboratories).
Chemical Synthesis of Bis-triazole Compounds 1 and 2
The two compounds were prepared by a reaction of the
corresponding acid (trans-trans-muconic acid and fumaric acid,
respectively) with diaminoguanidine monohydrochloride in poly-
phosphoric acid as the dehydrating agent, following the procedure
already described in [13]. The chlorohydrates 1 and 2 were
prepared as follows. Each bis-diaminotriazole was suspended in
water. Diluted hydrochloric acid (10 mL conc. in 100 mL water)
was added, heated to ebullition until the solid was completely
dissolved. Upon cooling to room temperature, 2 was obtained as
brown prismatic crystals. In the case of 1, the chlorohydrate (pale
brown prismatic crystals) was obtained upon addition of ethanol to
the water solution and cooling to room temperature. The structure
of the chlorohydrates and the protonation at the N-2 atom of the
ring, instead of at the amino groups, was confirmed by single
crystal analysis (work in preparation) and is consistent with similar
results reported in [13].
Treatments
L-carnosine, supplied by Sigma-Aldrich Canada, was dissolved
in DMEM without phenol red (Sigma–Aldrich). HCT-116 cells
were plated at a concentration of 3.06106 cells in 100 mm plates.
After incubation for one day at 37uC in 5% CO2, L-carnosine was
added from 0.5 to 100 mM; the cells were incubated at 37uC and
harvested 24 h after. The treatment with the bis-diaminotriazole
compounds (1 and 2) was carried out under the same conditions
using concentrations from 0.05 to 0.5 mM. For CoCl2 treatment
100 mM CoCl2 was added to HCT-116 for 6 h. MG132, supplied
by Calbiochem USA was dissolved in dimethyl sulfoxide (DMSO)
and was added to the culture medium. HCT-116 cells were
incubated for 1 h prior to L-carnosine treatment [14]. 24 h after
L-carnosine treatment the cells were harvested for protein
immunoprecipitation.
Fluorescence Microscopy
HCT116 cells were grown on slides for 24 h and treated with
100 mM L-carnosine. After 24 h, cells were washed with PBS and
fixed with cold 4% paraformaldehyde in PBS at room temperature
for 10 min and then were permeabilized with 0.4% TRITON
X100 in PBS 1X. After 10 min, cells were washed twice with PBS
1X/0.4% bovine serum albumin (BSA) for 1 h at room
temperature. The cells were first treated with HIF-1a antibodies
(Santa Cruz Biotechnology, Santa Cruz, CA) in PBS 1X/0.4%
BSA for 1 h at room temperature and subsequently with ALEXA
568 (Molecular Probes’ Alexa Fluor 568) secondary antibodies in
PBS 1X/0.4% BSA for 1 h at room temperature in the dark. After
washing with PBS, cells were stained with mounting medium for
fluorescence with DAPI (Vector laboratories). Results were
examined by fluorescence microscopy on a Zeiss Axiophot at
40X resolution.
Antioxidant Activity Measurement by the DPPH Method
DPPH (1,1-diphenyl-2-picrylhydrazyl) quenching method was
employed for the evaluation of the antioxidant activity of 1, 2 and
L-carnosine [15]. The ability of the samples to scavenge the DPPH
radical was measured using the Brand-Williams method [16].
Aliquots (60 mL) of 1 mM solution of 1, 2 and L-carnosine were
added to 3 mL of DPPH solution (661024 M) and the absorbance
was determined at 515 nm (Philips PU 8620 series UV/Visible
spectrophotometer) every 5 min until the steady state. For each
antioxidant assay, a trolox aliquot was used to develop a 50–
500 mM standard curve. All the data were then expressed as
Trolox Equivalents (mmol TE/L).
Analysis of Cell Viability
The MTT assay was performed according to the protocol
previously reported [17]. HCT-116 cells were plated at a density
of 16105 cells in 96-well plates. Subsequently, the bis-diamino-
triazole compounds (1 and 2) were assayed using concentrations
from 0.05 to 0.5 mM. After 24 h of incubation, 10 mL of 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT)
(Sigma Aldrich) (0.05 mg/mL) were added to the culture medium.
After 4 h at 37uC the culture medium was removed and 200 mL of
DMSO were added to dissolve the salts of formazan. The
absorbance was measured with a 96-wells plate spectrophotometer
at 570 nm. The experiments were independently performed three
times and each experiment contained triple replicates. Control
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samples containing a complete culture medium devoid of cells or
control cells without L-carnosine were also included in each
experiment.
Clonogenic Assay
HCT116 cells were plated at a density of 500 cells/well in 12-
well plates in 500 mL of fresh culture medium containing complete
DMEM with 20–50–100 mM L-carnosine or bis-diaminotriazole
compounds (1 and 2) (from 0.05 to 0.5 mM). After 7 days, the cells
were washed twice with PBS 1X and stained with a solution of
0.2% crystal violet, 50% methanol and 10% acetic acid in H2O for
30 min at room temperature. Subsequently the cells were washed
with deionized H2O and photographed.
Measurement of Reactive Oxygen Species (ROS)
The formation of ROS was evaluated by means of the 2,7-
dichlorofluorescein-diacetate probe (H2DCF-DA) (purchased
from Sigma–Aldrich). HCT-116 cells were plated at a density of
56103 cells/well in 96-well plates in 100 mL of fresh culture
medium containing DMEM without phenol red. Cells were
allowed to grow for 24 h at 37uC in 5% CO2, then L-carnosine
(from 0.5 to 100 mM) or compounds 1 and 2 (from 0.05 to
0.5 mM) were added to the culture medium. The ROS measure
was performed according to the protocol previously reported [18].
Fluorescence was monitored using a LS 55 Fluorescence
Spectrometer (Perkin–Elmer Ltd., Beaconsfield, England). In each
experiment, the fluorescence increase was measured in three
replicate cultures for each treatment.
Transfection Assay and Luciferase Reporter Assay
The cells were transfected with the hypoxia response element
(HRE)-luciferase reporter plasmid or with a vector containing the
oxygen-dependent degradation (ODD) domain of HIF-1a, using
Lipofectamine 2000 (Invitrogen, Darmstadt, Germany) in the
serum-free OptiMEM-1 medium (Lonza, Verviers, Belgium),
according to the manufacturer’s specifications. Cultures were
maintained at 37uC in 5% CO2 for 24–48 h. Luciferase activity
was evaluated by the Dual-Luciferase Reporter assay system
(Promega, Madison WI, USA) and with a Promega GloMax 20/
20 Luminometer, according to the manufacturer’s specifications.
Preparation of Total, Nuclear and Cytosolic Protein
Extracts
Total extracts of HCT-116 were prepared 24 h after treatment
with L-carnosine from 0.5 to 100 mM or with 1 or 2 from 0.05 to
0.5 mM. The samples were washed twice with ice-cold PBS 1X
Figure 1. L-carnosine affects HIF-1a protein expression. (A) HIF-1a mRNAs were measured by real time PCR in a total RNA preparation from
HCT-116 cells 24 h after L-carnosine treatment. White bars indicate fold changes of mRNA with respect to the amount of HIF-1a mRNA in untreated
cells reported as value 1; (B) western blotting analysis of total protein extracts from HCT-116 cells 24 h after L-carnosine and (C) L-carnosine and CoCl2
treatment probed with HIF-1a and b-actin antibodies. Related histograms report the densitometric values of HIF-1a/b-actin ratio. The densitometric
values represent the mean 6 SDs of three independent experiments. The differences were considered significant at **p,0.001, ***p,0.0001.
doi:10.1371/journal.pone.0096755.g001
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and centrifuged at 240 g for 10 min at 4uC. The cell pellet was
resuspended in a cold lysis buffer containing 1% Triton X100,
0.1% SDS, 0.1% NaN3, 100 mM NaCl, 50 mM NaF, 0.1 mM
Na3VO4, 10 mM NaPPi, 0.5 mM PMSF and 10 mg/mL aproti-
nin, leupeptin and pepstatin at 4uC for 30 min on ice. The cell
lysates were centrifuged at 20,000 g for 10 min at 4uC. For
cytosolic and nuclear extracts HCT116 cells were harvested,
washed twice with ice-cold PBS 1X and centrifuged at 2406g for
10 min at 4uC. The cell pellet was resuspended in 100 mL of ice-
cold hypotonic lysis buffer (10 mM HEPES pH 7.9, 10 mM KCl,
1 mM PMSF, 0.1 mM EDTA, 0.1 mM EGTA, 1 mM DTT,
1 mM Na3VO4, 10 mg/mL each of aprotinin, leupeptin, and
pepstatin) and incubated with shaking at 4uC for 15 min. Next, the
cells were lysed by adding 5% NP40. The cellular extract was
centrifuged for 5 min at 5006g and the supernatant containing
the cytosolic fraction was then obtained after further centrifugation
for 10 min at 20.0006g.
The nuclear pellet was resuspended in high salt extraction
buffer (20 mM HEPES pH 7.9, 0.4 M NaCl, 1 mM PMSF,
1 mM EDTA, 1 mM EGTA, 1 mM DTT, 10 mg/mL each of
aprotinin, leupeptin, and pepstatin) and incubated with shaking at
4uC for 15 min. The nuclear extract was then centrifuged for
15 min at 20.0006g, and the supernatant was aliquoted and
stored at 280uC. Protein concentration was determined by a Bio-
Rad protein assay kit (Bio-Rad Laboratories). For the western blot
analyses, the proteins obtained were challenged with antibodies
against HIF-1a (rabbit polyclonal antibody from Santa Cruz
Biotechnology), aldolase A (ABNOVA), aldolase C (rabbit
polyclonal antibody from Santa Cruz Biotechnology) and b-actin
(mouse monoclonal from Santa Cruz Biotechnology). The signals
were detected by using the ECL kit (GE Healthcare).
Figure 2. L-carnosine reduces the HIF-1a protein level affecting its stability and induces HIF-1a proteasome-dependent
degradation. (A) Western blotting analysis probed with anti-HIF-1a antibody of immunoprecipitated proteins in HCT-116; (B) western blotting
analysis of total protein extracts from HCT-116 cells 24 h after L-carnosine (100 mM) or L-carnosine (100 mM) plus 10 mM cycloheximide (CHX)
treatment probed with HIF-1a and b-actin antibodies. Related histograms report the densitometric values of HIF-1a/b-actin ratio; (C) western blotting
analysis of total protein extracts from HCT-116 cells 24 h after L-carnosine (100 mM) or L-carnosine (100 mM) plus 1 mM MG132 treatment probed
with HIF-1a and b-actin antibodies. The densitometric values represent the mean 6 SDs of three independent experiments. The differences were
considered significant at **p,0.001, ***p,0.0001; (D) Schematic representation of ODD-LUC reporter vector. ODD-LUC vector contains the oxygen-
dependent degradation (ODD) domain of HIF-1a cloned upstream from the luciferase gene. The luciferase activity was measured 48 h after
transfection and represents the mean 6 SDs of three independent experiments. The values have been reported as percentages of luciferase activity
compared to 100% of untreated cells.
doi:10.1371/journal.pone.0096755.g002
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Immunoprecipitation
HCT-116 cells were lysed in RIPA buffer (50 mM Tris-HCl
pH 8.0, 250 mM NaCl, 0.1% SDS, 1% NP-40, 1% sodium
deoxycholate, 5 mM EDTA, and 1 mM DTT) supplemented with
protease inhibitors. The samples (800 mg) were precleared with
30 mL of Protein A/G PLUS-Agarose (Santa Cruz Biotechnology)
for 2 h at 4uC. The anti-HIF-1a antibody (rabbit polyclonal
antibody from Santa Cruz Biotechnology) was added to lysate and
incubated overnight at 4uC and then 30 mL of Protein A/G
PLUS-Agarose were added to the lysate. After 1 h at 4uC the
proteins were recovered in Laemmli buffer, resolved on 8%
denaturing gel and then subjected to immunoblotting.
Real-time PCR Assay
Total RNA was prepared from HCT-116 cells by using the
RNeasy mini kit (Qiagen) and was used to synthesize the cDNA
with random hexanucleotide primers and MultiScribe reverse
transcriptase (Invitrogen) at 48uC for 1 h. The cDNA was then
amplified in an iCycler iQ real time PCR detection system (Bio-
Rad Laboratories) using iQTM SYBR Green Supermix (Bio-Rad
Laboratories). The Real-Time PCR reactions and relative
quantification gene expression were performed as reported in
[19]. The ratios between 2–DDCT before treatment with L-
carnosine and those calculated for the samples incubated with L-
carnosine from 5 to 100 mM are expressed as fold changes.
Statistical Analysis
Results were expressed as the mean6 SDs (standard deviations)
of three independent experiments. The statistical analysis was
performed using one-way analysis of variance ANOVA and P
value for a multiple comparison test. The level of statistical
significance was defined as **p,0.001, ***p,0.0001 [2]. The
Figure 3. L-carnosine affects HIF-1a nuclear translocation reducing its transcriptional activity in HCT-116 cells. (A) Western blotting
analysis of cytosolic and (B) nuclear protein extracts from HCT-116 cells 24 h after 20–50–100 mM L-carnosine treatment probed with HIF-1a, b-actin
and Histone H3 antibodies. Related histograms report the densitometric values of HIF-1a/b-actin and HIF-1a/H3 ratio. The densitometric values
represent the mean 6 SDs of three independent experiments. The differences were considered significant at ***p,0.0001; (C) HCT-116 treated with
CoCl2 and 100 mM L-carnosine for 24 h examined with fluorescence microscope at 40x magnification using filters for secondary antibody against
HIF-1a protein and for 49-69-diaminodino-2-phenylindole (DAPI); (D) Schematic representation of HRE-LUC reporter vector. HRE-LUC vector contains
nine repeat sequences of the Hypoxia Response Element (HRE) cloned upstream from the luciferase gene. The luciferase activity was measured 48 h
after transfection and represents the mean 6 SDs of three independent experiments. The values have been reported as percentages of luciferase
activity compared to 100% of untreated cells.
doi:10.1371/journal.pone.0096755.g003
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analyses were performed using GraphPad PRISM software
(version 3.0; GraphPad Software, Inc.: La Jolla, CA, USA,
2002) on a Windows platform.
Results
L-carnosine Reduces HIF-1a Protein Levels Affecting its
Stability in HCT-116 Cells
In order to establish the effect of the dipeptide L-carnosine on
the expression of the HIF-1a transcription factor, human colon
carcinoma cells (HCT-116) were treated with different concen-
trations of L-carnosine (from 0.5 to 100 mM). In particular, RT-
PCR analysis, 24 h after L-carnosine addition, revealed a steady
state of HIF-1a mRNAs levels, compared to untreated control
cells (Figure 1A). Next, we evaluated the effects of L-carnosine on
HIF-1a protein expression in the HCT-116 cells by western blot
analysis. The protein levels were assessed both in hypoxia and
normoxia, as well as in the presence (from 0.5 to 100 mM) and
absence of L-carnosine. In the HCT-116 normoxic cells, 50–
100 mM of L-carnosine reduced the expression of HIF-1a
compared to a control sample not treated with L-carnosine
(Figure 1B). We also observed that the hypoxia-induced (by CoCl2)
expression of HIF-1a decreased after treatment with 50 or
100 mM L-carnosine (Figure 1C). The blots were re-probed with
antibodies against b-actin to confirm the protein load equivalence.
To confirm the reduction of HIF-1a we performed an immuno-
precipitation assay. We found that the HIF-1a-antibody immu-
noprecipitate contained significant levels of HIF-1a protein only in
the control sample (Figure 2A). In addition, we investigated the
effect of L-carnosine upon HIF-1a protein synthesis in cells treated
with cycloheximide (CHX). The analysis of HIF-1a protein
stability in CHX-treated cells showed that the level of HIF-1a
decreased in L-carnosine treated cells (50–100 mM), suggesting
that L-carnosine affects the HIF-1a protein stability (Fig. 2B).
Furthermore, we examined if this dipeptide could be involved in
the proteasome degradation of HIF-1a. Therefore, we evaluated
by western blot analysis the effect of the proteasome inhibitor
MG132 on HIF-1a protein levels after treatment with 50–
100 mM of L-carnosine. As shown in Figure 2C, the treatment
with 1 mM MG132 and L-carnosine for 24 h increased the HIF-
1a protein level compared to untreated control cells or to cells
treated with MG132 alone. A further indication for the
involvement of L-carnosine in HIF-1a proteasome degradation
was obtained by transfection of a vector containing the ODD
domain of HIF-1a. As shown in Figure 2D, the luciferase activity
decreased noticeably 24 h after treatment with L-carnosine
(100 mM).
L-carnosine Influence HIF-1a Nuclear Translocation
Reducing the Transcriptional Activity of Hypoxia
Responsive Element (HRE) and the Expression of Its
Downstream Genes
Stabilized HIF-1a protein translocates from the cytoplasm to
the nucleus where it dimerizes with HIF-1b forming the
transcriptionally active HIF-1 complex. Therefore, the nuclear
localization of HIF-1a is essential for the transcriptional activity of
HIF-1a. The effect of L-carnosine on the intracellular localization
of HIF-1a was analysed at a first step by western blotting assay
using cytoplasmic and nuclear protein fractions, and subsequently
Figure 4. L-carnosine reduces HIF-1a dependent gene transcription in HCT-116 cells. (A) The table reports the primer sequences used in
the Real Time PCR experiments; (B) aldolase A and PDK-1 mRNAS were measured by real time PCR in a total RNA preparation from HCT-116 cells 24 h
after L-carnosine treatment. Bars indicate fold changes of mRNAS with respect to the amount of aldolase A and PDK1 mRNAs in untreated cells
reported as value 1; (C), (D) and (E) western blotting analyses of total protein extracts from HCT-116 cells 24 h after L-carnosine treatment probed
with aldolase A, Aldolase C, GLUT-1 and b-actin antibodies. Histograms report the densitometric values of aldolase A/b-actin ratio, aldolase C/b-actin
ratio and GLUT-1/b-actin ratio. The densitometric values represent the mean 6 SDs of three independent experiments. The differences were
considered significant at **p,0.001, ***p,0.0001.
doi:10.1371/journal.pone.0096755.g004
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by immunofluorescence analysis. As shown in Figures 3A and 3B,
L-carnosine influences the translocation of HIF-1a from the
cytoplasm to the nucleus. In fact, when HCT-116 cells were
treated with L-carnosine the nuclear protein levels of HIF-1a
decreased noticeably, whereas the cytosolic levels were not
affected. Also in the immunofluorescence analysis (Figure 3C)
the HIF-1a signal in L-carnosine treated cells was weakly
detectable compared to untreated control cells or to CoCl2-treated
cells. In cancer cells, the activation of the HIF-1 complex entails its
association with the HRE motif in the regulatory regions of target
genes involved in the glycolytic process. For this reason, HCT-116
cells were transiently transfected with the HRE-luciferase reporter
plasmid. As shown in Figure 3D, the treatment with 100 mM L-
carnosine caused appreciable decrease in luciferase activity (24 h
after the treatment). Subsequently, we evaluated the mRNAs of
some HIF-1a-dependent genes. We measured by RT-PCR
analysis the effects of different concentrations of L-carnosine
(0.5, 5, 50 and 100 mM) on mRNA levels of aldolase A and PDK-
1. As shown in Figure 4B, aldolase A and PDK-1 mRNAs levels
decreased after treatment with L-carnosine, especially between 50
and 100 mM. The western blot analysis of aldolase A demon-
strated also a reduction of the protein level (Figure 4C). In
addition, we observed that the expression of the GLUT-1 protein,
as well as of the aldolase C protein, decreased after L-carnosine
treatment (Figure 4D and 4E). Aldolase C is a brain-specific
isoform of aldolase, but recently it has been demonstrated that the
mRNA level of aldolase C is 30-fold higher in human gastric
cancer cell lines. The oligonucleotide sequences used in the RT-
PCR analyses are reported in Figure 4A.
The Antioxidant Effect of Compounds 1 and 2 Compared
to L-carnosine
The generation of Reactive Oxygen Species (ROS) during
hypoxia provides a redox signal for HIF-1a induction. In fact,
some authors define ROS as positive regulators of HIF-1a [20].
The observation that other antioxidant substances can influence
the level of HIF-1a protein led us to evaluate the antioxidant
Figure 5. Compounds 1, 2 and L-carnosine strongly reduce the production of intracellular ROS. (A) Chemical structures of compounds 1
and 2; (B) Antioxidant activity of L-carnosine, 1 and 2 measured by the DPPH method as described in Section 1.2.4; (C) ROS production evaluated
24 h after the addition of L-carnosine, 1 and 2 in HCT-116 cells by the probe 29,79-dichlorofluorescein-diacetate (H2DCF-DA). All values represent the
mean 6 SDs of three independent experiments and are expressed as a percentage compared to 100% of control cells. The differences were
considered significant at **p,0.001, ***p,0.0001.
doi:10.1371/journal.pone.0096755.g005
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activity of two novel bis-diaminotriazole compounds (1 and 2)
(Figure 5A), in comparison to that of L-carnosine, by DPPH
assay. First, we measured the percentage of DPPH inactivation
using a 1 mM concentration for all compounds, and we
demonstrated that compounds 1 and 2 possess a major activity
as ROS scavengers compared to L-carnosine (see the Table in
Figure 5B). Next, we examined the intracellular ROS genera-
tion induced by L-carnosine (100 mM) in HCT-116 cells and
compared it with the amount of ROS generated by treating the
same cell line with different concentrations (from 0.05 to
0.5 mM) of compounds 1 and 2. As shown in Figure 5C, the
treatment with, 0.1 and 0.5 mM of 1 and 2 reduced the
intracellular ROS generation in HCT-116 by about 40–50%,
similarly to 50–100 mM L-carnosine. Finally, we also evaluated
the effect of different concentrations of 1 and 2 (from 0.05 to
0.5 mM) on the HIF1-a expression and cell viability. As shown
in Figures 6A and 6B, the addition of 1 and 2 did not affect
the HIF-1a protein levels nor the cell proliferation. In addition,
we evaluated by clonogenic survival assay the ability of HCT-
116 cells to proliferate and to form a large colony or a clone in
the presence of L-carnosine or 1 or 2 (Figure 6C). 50 mM L-
carnosine reduced significantly the number of colonies with
respect to the untreated control sample, whereas compounds 1
and 2 did not influence the cells ability to form colonies at the
tested concentration. A flow cytometry assay (FACS) confirmed
that 1 and 2 did not affect the cell cycle and did not induce
apoptosis in HCT-116 cells (data not shown). The early
apoptotic death rate in HCT-116 cells treated with the two
compounds was not significantly different from the control
sample.
Discussion
In this study, we evaluated the effect of L-carnosine treatment
on HIF-1a activity in human colon cancer cells. It has been
reported that HIF-1a protein is over-expressed in many types of
human cancer, including lung, breast, prostate, stomach, and
colon carcinomas [21–22]. The expression of HIF-1 is enhanced
by genetic alterations in tumour suppressor genes (p53, PTEN)
and oncogenes (v-src, HRAS) and by the induction of several
Figure 6. Compounds 1 and 2 have no effect on the HIF-1a protein level and cell proliferation in HCT-116. (A) Western blotting analysis
of the total protein extracts from HCT-116 cells after treatment with compounds 1 and 2 probed with HIF-1a and b-actin antibodies. Histograms
report the densitometric values of HIF-1a/b-actin ratio. The densitometric values represent the mean 6 SDs of three independent experiments; (B)
the cell proliferation was measured by MTT assay in HCT-116 cells 24 h after treatment with compounds 1 and 2. All values represent the mean 6
SDs of three independent experiments and are expressed as a percentage compared to 100% of control cells; (C) Clonogenic survival assay in HCT-
116 after treatment with L-carnosine (50 mM) or compounds 1 and 2 (0.5 mM) with respect to untreated cells.
doi:10.1371/journal.pone.0096755.g006
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growth factors (IGF1 and IGF2, the basic fibroblast growth
factor, and the EGF) [23–24]. Indeed, the homogeneous HIF-1
immunostaining pattern in several colon carcinoma cell lines is
associated with these factors [25]. Particularly, in HCT-116
colon carcinoma cells, HIF-1a and HIF-2b regulate the cancer
metabolism by overlapping with the KRAS oncogene [26]. We
previously demonstrated that L-carnosine could abate ROS
induced by the KRAS oncogene as well as the production of
ATP [2]. In addition, an investigation with a proteomic
approach supports the possibility that the dipeptide L-carnosine
affects tumour cell growth in the human glioma cells by
interfering with protein folding/processing or with HIF-1a
signalling [4]. According to these observations, we have found,
in HCT-116 cell line, that the levels of HIF-1a mRNAs are
steady in the presence of L-carnosine, thus indicating that HIF-
1a is not regulated at the transcription level. This result is not
surprising because the expression of HIF-1a mRNA seems to be
constitutive [27]. Nevertheless, in the same conditions this
dipeptide decreased HIF-1a protein level, acting on its stability.
Indeed, we have treated HCT-116 cells with L-carnosine in
presence of cycloheximide, to inhibit the de novo protein
synthesis, or in the presence of the proteasome inhibitor
MG132. We found that L-carnosine reduced HIF-1a stability
and induced its proteasome degradation. In addition, the
transfection assay with the ODD domain-vector suggests that
L-carnosine somehow acts via the oxygen-dependent degrada-
tion domain. Another interesting point concerns the finding that
L-carnosine treatment affected the nuclear amount of HIF-1a,
because the nucleus localization of this transcriptional factor is
required to its transcriptional activity. For this reason, HCT-116
cells were transiently transfected with the hypoxia response
element (HRE)-luciferase reporter plasmid, containing the
sequence recognized by HIF-1a. We have found that in the
cells treated with L-carnosine the luciferase activity decreased
appreciably compared to the untreated control cells. Since HIF-
1a represents one of the main responsible for the metabolic
switch from mitochondrial respiration to glycolysis (Warburg
effect) in tumour cells, we analysed some HIF-1a -dependent
genes, involved in these molecular pathways. Then we evaluated
the expression of Aldolase A and PDK-1 by Real Time PCR.
The mRNAs levels of the aldolase A and PDK-1 decreased as
well as GLUT-1, aldolase A and C protein levels. In particular,
aldolase C is a brain-specific isoform of aldolase and it has been
demonstrated that the mRNA level of this enzyme is 30-fold
higher in human gastric cancer cell lines. [28]. In brief, L-
carnosine acts on HIF-1a signalling decreasing its protein level
and consequently its transcriptional activity. In recent years, it
has been of particular interest the role of ROS and of
antioxidant molecules in HIF-1a regulation [12]. Indeed, several
experimental data demonstrate the ability of some antioxidants
to suppress tumorigenesis by inhibiting HIF-1a [29]. Therefore,
we have evaluated the effect on HIF-1a expression of two
compounds, 1 and 2 in Figure 6A, obtained by organic
synthesis and prepared by the reaction of the corresponding
trans-trans-muconic and fumaric acid, respectively. We found
that 1 and 2 did not influence the cell viability and HIF-1a
protein level, although they have the same ability in reducing
intracellular ROS levels compared to L-carnosine in HCT-116
cell line. We have also demonstrated by DPPH assay that these
compounds, unlike L-carnosine, have a good activity as ROS
scavengers. This finding could be not surprising because it has
been reported that L-carnosine could exercise its antioxidant
activity inhibiting the radical production by binding copper
ions, interacting with lipid peroxidation products and inhibiting
AGE (Advanced Glycation End product) formation, which are
end products of the non-enzymatic glycation of proteins.
Indeed, AGEs bind the receptors for AGEs (RAGE) on the
cellular membrane, inducing oxidative stress and increasing
ROS production [30]. It has also been demonstrated that L-
carnosine prevents AGE formation in vivo and reacts with
protein carbonyl groups protecting the macromolecules against
their cross-linking actions [31]. In addition, Bento et al. propose
a model for methylglyoxal-dependent degradation of HIF-1a, in
which MGO promotes an increased association of Hsp40/70.
This association leads to the recruitment of the carboxyl
terminus Hsc70-interacting protein (CHIP) and, consequently,
the polyubiquitination and proteasome degradation of HIF-1a
[32]. However, a proteomics study in glioblastoma cells treated
with L-carnosine shows a decrease in the protein expression of
BAG2, involved in the inhibition of the ubiquitin ligase activity
of CHIP. Therefore, the reduction of this protein may
destabilize HIF-1a [4]. In accordance with these observations
we presume that the analysis of the mechanism by which L-
carnosine reduces ROS level and mostly the study of its
potential targets could be critical to elucidate how L-carnosine
influences HIF-1a as well the mechanism underlying its anti-
proliferative effect on colon cancer cells. Further studies will also
be needed to assess the possible involvement of PHDs in the
HIF-1a degradation and to evaluate the effect on HIF-1a of
natural inhibitors of nitric oxide (NO), available from our
laboratories, since it has been demonstrated that NO can
regulate HIF-1a activation [33–34].
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